The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage

Surgical Neurology

Volumn 71, Issue 1, 2009, Pages 54-59

  Cosar, Murat ^a   Eser, Olcay ^a   Fidan, Huseyin ^a   Sahin, Onder ^a   Buyukbas, Sadik ^b   Ela, Yuksel ^a   Yagmurca, Murat ^a   Ozen, Oguz A ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Brain ischemia; Dexmedetomidine; Neuroprotective; Subarachnoid hemorrhage

Indexed keywords

DEXMEDETOMIDINE; MALONALDEHYDE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN VASOSPASM; CISTERNA MAGNA; CONTROLLED STUDY; CRANIOTOMY; ENZYME ACTIVITY; HIPPOCAMPUS; HISTOPATHOLOGY; LEFT HEMISPHERE; NEUROPROTECTION; NONHUMAN; RABBIT; RIGHT HEMISPHERE; SUBARACHNOID HEMORRHAGE; SYMPATHETIC INNERVATION;

ANIMALS; ANTIOXIDANTS; DEXMEDETOMIDINE; HIPPOCAMPUS; MALE; MALONDIALDEHYDE; NEUROPROTECTIVE AGENTS; OXIDANTS; RABBITS; SUBARACHNOID HEMORRHAGE; SUPEROXIDE DISMUTASE; VASOSPASM, INTRACRANIAL; XANTHINE OXIDASE;

EID: 57349177060     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2007.08.020     Document Type: Article

References (30)

1. Aydi{dotless}n I.H., and Onder A. The effect of very early cisternal irrigation on basilar artery spasm SAH in rat model. Acta Neurochir (Wien) 113 (1991) 69-73
2. Awad I.A., Carter L.P., Spetzler R.F., Medina M., and Williams F.C. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 18 (1987) 365-372
3. Bunc G., Kovacic S., and Strnad S. Sympathetic nervous system exclusion following experimental subarachnoid haemorrhage prevents vasospasm in rabbits. Wien Klin Wochenschr 112 (2000) 533-539
4. Draper H.H., and Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186 (1990) 421-431
5. Durak I., Yurtarslani Z., Canbolat O., and Akyol O. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta 214 (1993) 103-104
6. Eser O., Cosar M., Fidan H., Sahin O., Buyukbas S., Ela Y., and Songur A. The effect of dexmedetomidine in the prefrontal cortex of rabbits after subarachnoidal hemorrhage. Neurol Psychiatry Brain Res 13 (2006) 189-194
7. Globus M.Y., Busto R., Dietrich W.D., Martinez E., and Ginsberg M.D. Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia. Neurosci Lett 91 (1988) 36-40
8. Granger D.N., and Korthuis R.J. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol 57 (1995) 311-332
9. Hoffman W.E., Kochs E., and Werner C. Dexmedetomidine improves neurological outcome from incomplete ischemia in the rat. Anesthesiology 75 (1991) 328-332
10. Ilhan A., Aladag M.A., Kocer A., Boluk A., Gurel A., and Armutcu F. Erdosteine ameliorates PTZ-induced oxidative stress in mice seizure model. Brain Res Bull 65 (2005) 495-499
11. Johansson P., and Ehrenstrom F. Presynaptic alpha-adrenoceptor regulation of transmitter release in the conscious rat. Comp Biochem Physiol 89 (1988) 65-69
12. 2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur J Pharmacol 372 (1999) 31-36
13. Kajita Y., Takayasu M., and Dietrich H.H. Possible role of nitric oxide in autoregulatory response in rat intracerebral arterioles. Neurosurgery 42 (1998) 834-841
14. Kanko M., Maral H., and Akbas M.H. Protective effects of clopidogrel on oxidant damage in a rat model of acute ischemia. Tohoku J Exp Med 205 (2005) 133-139
15. Kuhmonen J., Pokorny J., and Miettinen R. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus following transient global ischemia. Anesthesiology 87 (1997) 371-377
16. Kemaloglu S., Ozkan U., Yilmaz F., Ak E., Acemoglu H., and Olmez G. Preventive effects of intracisternal alpha-tocopherol on cerebral vasospasm in experimental subarachnoid haemorrhage. Yonsei Med J 44 (2003) 955-960
17. Lambert G., Naredi S., and Edin E. Sympathetic nervous activation following subarachnoid hemorrhage: influence of intravenous clonidine. Acta Anaesthesiol Scand 46 (2002) 160-165
18. Lobato R.D., Marin J., and Salaices M. Cerebrovascular reactivity to noradrenaline and serotonin following experimental subarachnoid hemorrhage. J Neurosurg 53 (1980) 480-485
19. Ma D., Hossain M., Rajakumaraswamy N., Arshad M., Sanders R.D., Franks N.P., and Maze M. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol 502 (2004) 87-97
20. Maeir C., Steinberg G.K., and Sun G.H. Neuroprotection by the α-2 adrenoceptor agonist dexmedetomidine in focal model of cerebral ischemia. Anesthesiology 79 (1993) 1-7
21. 2-adrenoceptor agonist, dexmedetomidine, selectively attenuates ischemia-induced increases in striatal norepinephrine concentrations. Brain Res 627 (1993) 325-329
22. Naredi S., Lambert G., and Eden E. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 31 (2000) 901-906
23. Peerless S.J., and Yasargil M.G. Adrenergic innervation of the cerebral blood vessels in the rabbit. J Neurosurg 35 (1971) 148-154
24. Prajda N., and Weber G. Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett 59 2 (1975) 245-249
25. Solomon R.A., Antunes J.L., and Chen R.Y.Z. Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: a new model. Stroke 16 (1985) 58-64
26. Songur A., Sarsilmaz M., Sogut S., Ozyurt B., Ozyurt H., Zararsiz I., and Turkoglu A.O. Hypothalamic superoxide dismutase, xantine oxidase, nitric oxide, and malondialdehyde in rats fed with fish ω-3 fatty acids. Prog Neuro-psychopharmacol Biol Psychiatry 28 (2004) 693-698
27. Sun Y., Oberley L.W., and Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 34 (1988) 497-500
28. Suzuki K., Sarti C., and Tuomilehto J. Stroke incidence and case fatality in Finland and in Akita, Japan: a comparative study. Neuroepidemiology 13 (1994) 236-244
29. Suzuki T., Akaike N., and Ueno K.I. MAO inhibitors, clorgyline and lazabemide, prevent hydroxyl radical generation caused by brain ischemia/reperfusion in mice. Pharmacology 50 (1995) 357-362
30. Zimmerman B.J., Grisham M.B., and Granger D.N. Role of oxidants in ischemia/reperfusion-induced granulocyte infiltration. Am J Physiol 258 (1990) 185-190